Eversept Partners, LP
NEW YORK, NY · CIK 1697013 · 13F filing filed 2025-02-14
SEC-registered investment adviser since 2017 · limited partnership
- Assets managed$2.7bn
- Staff10 · 5 in investment roles
- Main clients (by assets)Private funds 99%, Mutual funds and ETFs 1%
- Private funds3 (3 hedge) · $2.3bn gross assets
- Websiteeversept.com
- Form ADV · 2026-03-31SEC adviser record
- Legal entityEVERSEPT PARTNERS, L.P. (US)
- Kindhedge funds, futures
- Others nearbyNew York, NY, San Francisco, CA
As an employer
- Offices in1 country
- Private fundshedge 3
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| New York, NY (main office)United States | about 4 |
| San Francisco, CAUnited States | 1 |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
Options: 0 call positions (— notional), 3 put positions ($157.4m notional) – listed below, not included above.
Holdings, Q4 2024
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| NATERA INC NTRA | $138.8m14.32% | Added +6.6k |
| GSK PLC GSK | $123.8m12.78% | Reduced -395.4k |
| VERA THERAPEUTICS INC VERA | $67.7m6.98% | Reduced -450.1k |
| INSPIRE MED SYS INC INSP | $54.6m5.63% | Added +18.0k |
| HCA HEALTHCARE INC HCA | $52.8m5.45% | Added +46.7k |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | $49.4m5.10% | Reduced -992.5k |
| REVVITY INC RVTY | $43.8m4.52% | Reduced -77.2k |
| HEALTHEQUITY INC HQY | $37.1m3.83% | Added +67.6k |
| ZIMVIE INC ZIMV | $28.9m2.98% | Unchanged |
| PROTAGONIST THERAPEUTICS INC PTGX | $26.2m2.70% | Added +233.6k |
| BIO-TECHNE CORP TECH | $21.6m2.22% | Reduced -364.3k |
| CELLDEX THERAPEUTICS INC NEW CLDX | $18.2m1.88% | Added +154.9k |
| VIATRIS INC VTRS | $15.8m1.63% | Reduced -454.3k |
| UNITED THERAPEUTICS CORP DEL UTHR | $15.4m1.59% | Reduced -87.2k |
| VIRIDIAN THERAPEUTICS INC VRDN | $15.0m1.54% | Added +88.8k |
| BIOCRYST PHARMACEUTICALS INC BCRX | $14.9m1.54% | Added +1.4m |
| BRUKER CORP BRKR | $13.8m1.42% | New |
| EDWARDS LIFESCIENCES CORP EW | $12.6m1.30% | New |
| DEXCOM INC DXCM | $11.6m1.19% | New |
| CENTENE CORP DEL CNC | $11.4m1.18% | Added +53.5k |
| TELEFLEX INCORPORATED TFX | $11.0m1.13% | New |
| ELEVANCE HEALTH INC ELV | $10.8m1.11% | Added +9.7k |
| VAXCYTE INC PCVX | $10.4m1.08% | New |
| TRAVERE THERAPEUTICS INC TVTX | $8.5m0.88% | Reduced -379.6k |
| COMMUNITY HEALTH SYS INC NEW CYH | $8.5m0.87% | Reduced -5.9m |
| GUARDANT HEALTH INC GH | $8.4m0.87% | New |
| REPLIGEN CORP RGEN | $7.8m0.80% | Reduced -109.5k |
| IONIS PHARMACEUTICALS INC IONS | $7.5m0.78% | Reduced -256.4k |
| FORTREA HLDGS INC FTRE | $7.5m0.77% | Reduced -56.2k |
| NEWAMSTERDAM PHARMA COMPANY NAMS | $7.1m0.73% | Reduced -32.0k |
| ASTRAZENECA PLC SPONSORED ADR | $6.7m0.69% | New |
| LIQUIDIA CORPORATION LQDA | $6.7m0.69% | Added +433.4k |
| MEDPACE HLDGS INC MEDP | $6.3m0.65% | New |
| XENON PHARMACEUTICALS INC XENE | $6.1m0.63% | New |
| MANNKIND CORP MNKD | $5.9m0.60% | Reduced -1.1m |
| HUMANA INC HUM | $5.8m0.59% | Reduced -11.2k |
| HENRY SCHEIN INC HSIC | $5.6m0.57% | New |
| DANAHER CORPORATION DHR | $5.1m0.53% | Reduced -16.2k |
| SYNDAX PHARMACEUTICALS INC SNDX | $4.5m0.47% | Reduced -3.8m |
| PATTERSON COS INC PDCO | $4.5m0.47% | New |
| GOSSAMER BIO INC GOSS | $4.5m0.46% | Unchanged |
| EVOLUS INC EOLS | $4.2m0.44% | Reduced -70.0k |
| ICON PLC ICLR | $4.0m0.42% | Added +5.6k |
| SUPERNUS PHARMACEUTICALS INC SUPN | $3.8m0.39% | New |
| AVANTOR INC AVTR | $3.5m0.37% | Unchanged |
| PUMA BIOTECHNOLOGY INC PBYI | $3.0m0.31% | Reduced -297.2k |
| 2SEVENTY BIO INC TSVT | $3.0m0.30% | Added +5.6k |
| MERUS N V MRUS | $2.9m0.30% | Unchanged |
| MEREO BIOPHARMA GROUP PLC MREO | $2.7m0.28% | Unchanged |
| ZAI LAB LTD ZLAB | $2.7m0.28% | Reduced -32.3k |
| ARCUTIS BIOTHERAPEUTICS INC ARQT | $2.7m0.27% | Reduced -502.1k |
| DENTSPLY SIRONA INC XRAY | $2.7m0.27% | New |
| XOMA ROYALTY CORPORATION XOMA | $2.5m0.26% | Added +1.1k |
| ITEOS THERAPEUTICS INC ITOS | $1.7m0.17% | New |
| KARYOPHARM THERAPEUTICS INC COM | $1.4m0.15% | Reduced -3.5m |
| ZENAS BIOPHARMA INC ZBIO | $1.4m0.15% | Reduced -18.4k |
| SUTRO BIOPHARMA INC COM | $1.3m0.13% | Reduced -1.1m |
| INFLARX NV IFRX | $1.2m0.13% | Reduced -1.1m |
| AMARIN CORP PLC SPONS ADR NEW | $735.5k0.08% | Reduced -1.8m |
| ABSCI CORPORATION ABSI | $522.6k0.05% | Reduced -73.4k |
| ALECTOR INC ALEC | $378.2k0.04% | Reduced -132.7k |
| AUTOLUS THERAPEUTICS PLC AUTL | $232.4k0.02% | Reduced -307.7k |
Sold out since Q3 2024
| Security | Value then |
|---|---|
| INSMED INC INSM | $79.5m1.1m shares |
| BAUSCH HEALTH COS INC BHC | $12.5m1.5m shares |
| INTRA-CELLULAR THERAPIES INC ITCI | $9.1m124.5k shares |
| BIOHAVEN LTD BHVN | $6.6m132.5k shares |
| BROOKDALE SR LIVING INC BKD | $5.8m861.3k shares |
| PARAGON 28 INC FNA | $5.0m749.2k shares |
| KURA ONCOLOGY INC KURA | $3.8m192.4k shares |
| MOLINA HEALTHCARE INC MOH | $3.6m10.6k shares |
| STAAR SURGICAL CO STAA | $3.4m91.2k shares |
| IQVIA HLDGS INC IQV | $3.1m13.1k shares |
| MARAVAI LIFESCIENCES HLDGS I MRVI | $2.8m337.0k shares |
| TOURMALINE BIO INC TRML | $2.2m84.4k shares |
| NEVRO CORP NVRO | $1.8m313.8k shares |
| AEROVATE THERAPEUTICS INC | $1.0m485.1k shares |
| STOKE THERAPEUTICS INC STOK | $639.2k52.0k shares |
| AFFIMED N V AFMDQ | $559.3k166.5k shares |
| AC IMMUNE SA ACIU | $375.4k99.3k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| INVESCO QQQ TR QQQ · Put | $124.3m243.1k shares | Reduced |
| SPDR S&P 500 ETF TR SPY · Put | $17.5m29.8k shares | Reduced |
| ISHARES TR TLT · Put | $15.7m179.4k shares | New |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| COMMUNITY HEALTH SYS INC NEW CYH · 13G · filed 2026-02-17 | 5.7%≈ $26.5m |